Total Payments
$633.95
2024 Payments
$32.70
Companies
12
Transactions
42
Payment Breakdown by Category
Food & Beverage$633.95 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $633.95 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $228.67 | 16 | $0 (2018) |
| ABBVIE INC. | $78.09 | 4 | $0 (2024) |
| Lilly USA, LLC | $68.24 | 4 | $0 (2018) |
| Orexigen Therapeutics, Inc. | $55.82 | 4 | $0 (2018) |
| ARBOR PHARMACEUTICALS, INC. | $53.84 | 4 | $0 (2018) |
| IBSA Pharma Inc. | $52.85 | 3 | $0 (2020) |
| VIVUS, Inc. | $22.79 | 2 | $0 (2017) |
| Flexion Therapeutics, Inc. | $22.69 | 1 | $0 (2018) |
| Upsher-Smith Laboratories LLC | $15.33 | 1 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $12.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.70 | 2 | ABBVIE INC. ($32.70) |
| 2020 | $17.17 | 1 | IBSA Pharma Inc. ($17.17) |
| 2019 | $33.04 | 2 | IBSA Pharma Inc. ($21.33) |
| 2018 | $143.93 | 10 | ARBOR PHARMACEUTICALS, INC. ($38.83) |
| 2017 | $407.11 | 27 | Novo Nordisk Inc ($202.16) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2020 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $17.17 | General |
| Category: Endocrinology | ||||||
| 09/09/2019 | Janssen Biotech, Inc. | SIMPONI (Biological) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Immunology | ||||||
| 02/07/2019 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $21.33 | General |
| Category: Endocrinology | ||||||
| 12/03/2018 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $14.35 | General |
| Category: Endocrinology | ||||||
| 09/13/2018 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $22.69 | General |
| Category: Musculoskeletal | ||||||
| 08/28/2018 | ARBOR PHARMACEUTICALS, INC. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2018 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Obesity | ||||||
| 05/21/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Diabetes | ||||||
| 04/09/2018 | Lilly USA, LLC | FORTEO (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Bone Muscle Joint | ||||||
| 03/27/2018 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Obesity | ||||||
| 02/27/2018 | ARBOR PHARMACEUTICALS, INC. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/12/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.37 | General |
| 01/30/2018 | ARBOR PHARMACEUTICALS, INC. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2017 | VIVUS, Inc. | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Obesity | ||||||
| 11/14/2017 | Arbor Pharmaceuticals, Inc. | Edarbyclor (Drug) | Food and Beverage | Cash or cash equivalent | $15.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2017 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Endocrinology | ||||||
| 11/07/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 10/18/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.91 | General |
| 10/17/2017 | VIVUS, Inc. | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/19/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Diabetes | ||||||
| 09/18/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 09/12/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: OBESITY | ||||||
About Dr. Bryan Frank, M.D
Dr. Bryan Frank, M.D is a General Practice healthcare provider based in Yukon, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1649397753.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Frank, M.D has received a total of $633.95 in payments from pharmaceutical and medical device companies, with $32.70 received in 2024. These payments were reported across 42 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($633.95).
Ad
Practice Information
- Specialty General Practice
- Location Yukon, OK
- Active Since 03/23/2007
- Last Updated 05/06/2011
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649397753
Products in Payments
- Victoza (Drug) $129.69
- TRULICITY (Drug) $57.49
- CONTRAVE (Drug) $55.82
- Edarbyclor (Drug) $53.84
- Tirosint (Drug) $52.85
- Synthroid (Drug) $45.39
- Saxenda (Drug) $45.05
- QULIPTA (Drug) $32.70
- QSYMIA (Drug) $22.79
- Zilretta (Drug) $22.69
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $15.33
- Ozempic (Drug) $13.14
- NUEDEXTA (Drug) $12.71
- SIMPONI (Biological) $11.71
- Korlym (Drug) $11.21
- FORTEO (Drug) $10.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Yukon
Dr. Matthew Cole, Dds, DDS
General Practice — Payments: $4,079
General Practice $4,079
Grant Pitt, D.d.s, D.D.S
General Practice — Payments: $3,950
General Practice $3,950
Matthew Guffey, Dds, DDS
General Practice — Payments: $3,539
General Practice $3,539
William Reed, Dds, DDS
General Practice — Payments: $2,690
General Practice $2,690
Aaron Cohenour, D.d.s, D.D.S
General Practice — Payments: $1,332
General Practice $1,332
Dr. Eric Mead, D.d.s, D.D.S
General Practice — Payments: $1,224
General Practice $1,224